Best Practice

Principles of transparency and best practice

Annals of Clinical Neurophysiology (ACN) follows the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; http://doaj.org/bestpractice)

Table of Contents

1. Website
2. Name of the journal
3. Peer Review Process
4. Ownership and Management
5. Governing Body
6. Editorial Team and Contact Information
7. Copyright and Licensing
8. Author Fees
9. Process For Identifying And Dealing With Allegations Of Research Misconduct
10. Publication Ethics
11. Publishing Schedule
12. Access
13. Archiving
14. Revenue Sources
15. Advertising
16. Direct Marketing

1. Website

i. The URL of the official journal website is https://www.e-acn.org/. ii. Aims and scope statement (https://www.e-acn.org/about/index.php) iii. Readership (https://www.e-acn.org/about/index.php) iv. Authorship criteria (https://www.e-acn.org/authors/authors.php) v. pISSN: 2508-691X, eISSN: 2508-6960

2. Name of The Journal

The official journal name is Annals of Clinical Neurophysiology. The abbreviated name is Ann Clin Neurophysiol.

3. Peer review process (https://www.e-acn.org/authors/authors.php)

ACN adopts double blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. All submitted manuscripts will be initially evaluated by more than two experts in accordance with the review and revision guidelines of The Korean Society of Clinical Neurophysiology. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 4 weeks of the receipt of a manuscript, and the reviewers’ comments will be sent to the corresponding authors.

4. Ownership And Management

i. Ownership: The Korean Society of Clinical Neurophysiology (http://www.kscn.or.kr/).
ii. Management team (https://www.e-acn.org/about/editorial.php)

5/6. Governing Body/Editorial Team And Contact Information

The governing body is the Editorial Board of the journal (https://www.e-acn.org/about/editorial.php).

7. Copyright And Licensing

i. Copyright policy (https://www.e-acn.org/authors/authors.php)
All published papers become the permanent property of The Korean Society of Clinical Neurophysiology, and must not be published elsewhere without written permission. A copyright transfer form should be submitted to the Editorial Office through the electronic submission system at http://submit.e-acn.org upon acceptance.

ii. Licensing Information (https://www.e-acn.org/authors/access.php)
This is an open-access journal distributed under the terms of the Creative Commons Attribution Noncommercial license (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, and it is used only for noncommercial purposes.

8. Author Fees

The authors do not pay any page charges or article processing charges.

9. Process For Identifying And Dealing With Allegations Of Research Misconduct

When the journal faces suspected cases of research and publication misconduct–such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer’s appropriation of an author’s idea or data, and complaints against editors–the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flow-charts). Discussion and decisions on the suspected cases are carried out by the Editorial Board.

10. Publication Ethics

The journal adheres to the ethical guidelines for research and publication described by the Committee on Publication Ethics (COPE, http://publicationethics.org/resources/guidelines), the International Committee of Medical Journal Editors (ICMJE) Guidelines (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals (http://kamje.or.kr/).

i. Journal policies on authorship
Authorship credit should be based on (1) substantial contributions to the study conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All of the listed authors should meet these four conditions. The corresponding author should (1) be responsible for all communications with this journal from submission to publication, (2) keep coauthors informed and involved during the review process, and (3) correspond with members of the scientific community after the manuscript has been published.

Inappropriate authorship includes where individuals who have made scientific or technical contributions to the study contents or results are not included as authors without reasonable grounds, or where individuals who have not made scientific or technical contributions are included as authors (e.g., as a token of appreciation or respect). The order of authors on published articles or other types of publications must be determined impartially based on the extent of their contributions to the study irrespective of the relative position or status of the individuals. Individuals who have made only minor contributions to the study or article preparation should be mentioned in footnotes or in the preface rather than including them as authors.

ii. How the journal will handle complaints and appeals
The policies of the journal are primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal.
Except where described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics (COPE) (https://publicationethics.org/appeals).

iii. Who can complain or lodge an appeal?
The corresponding author, other authors, reviewers, and readers may register complaints and appeals in the following cases: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, unethical treatment of animals, absence of informed consent, bias or unfair/inappropriate competitive acts, copyright infringement, stolen data, defamation, and legal problems. Any individuals or institutions wanting to inform the journal about such cases can write to the Editor-in-Chief. Complaints or appeals should provide concrete data with answers to all factual questions, such as about who, when, where, what, how, and why.

iv. Who is responsible for handling and resolving complaints and appeals?
The Editor-in-Chief, Editorial Board, or Editorial Office.

v. What is the possible consequence or remedy?
The consequence or remedy will the vary with the type or degree of misconduct, and will follow the COPE guidelines.

vi. Journal policies on conflicts of interest and competing interests
(https://www.e-acn.org/authors/authors.php)
The corresponding author must inform the Editor-in-Chief of any potential conflicts of interest that could have influenced how the authors have interpreted the data. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academic-related issues. In particular, all sources of funding related to the study should be stated explicitly.

vii. Journal policies on data sharing and reproducibility
This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors” (https://doi.org/10.3346/jkms.2017.32.7.1051). The authors should contact the Editorial Office with any inquiries about the depositing of data.

viii. Journal policy on ethical oversight
When the journal encounters suspected cases of research and publication misconduct, such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, or complaints against editors, the resolution process will follow the flowchart provided by COPE (http://publicationethics.org/resources/flowcharts). The Editorial Board will discuss suspected cases, reach a decision, and then publish errata, corrigenda, clarifications, retractions, and/or apologies as necessary.

ix. Journal policy on intellectual property
All published papers become the permanent property of The Korean Society of Clinical Neurophysiology, and must not be published elsewhere without written permission.

x. Journal options for post-publication discussions and corrections
Post-publication discussions on any published articles can be initiated by sending a letter to the Editor-in-Chief. Any errors or mistakes in articles can be corrected via errata, corrigenda, or retractions.

11. Publishing Schedule

ACN is published twice yearly on April 30 and October 31.

12. Access

This is an open-access journal distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited, and it is used only for noncommercial purposes.

13. Archiving

The journal will be accessible without barriers from the Korea Citation Index (https://kci.go.kr) or the National Library of Korea (http://nl.go.kr) in the event that it is no longer published.

14. Revenue Sources

The journal receives financial support from the publisher (The Korean Society of Clinical Neurophysiology), the Korea government, and in-journal advertising.

15. Advertising

ACN accepts advertisements on the bases described below.

• Eligibility of advertised products or services
  All products or services should be safe and reliable, and not cause any harm to the health and welfare of humans. Advertisements may promote information and technologies relevant to authors, editors, reviewers, and readers. Pharmaceutical products may also be considered.
  - Advertising is separate from content. Advertisers and sponsors have no advance knowledge of the editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors do not influence any of the editorial decisions or advertising policies.
  - The journal reserves the right to decline or cancel any advertisement at any time.
  - Advertisements for pharmaceutical products must conform with all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea.
  
  
• Orders
  Any individuals or organizations who are interested in advertising their products or services in the print copies of the journal or on its website are encouraged to contact the Editorial Office. The acceptance of advertisement will be discussed by the Editorial Board and will ultimately be approved by the publisher.
  
  
• Advertisement fee
  The cost of an advertisement will follow the code of fair competition policy.
  
  
• Disclaimer
  Liability: Neither the publisher nor the editors will be legally liable for advertisements published in the journal. In addition, they do not guarantee the accuracy, completeness, or usefulness of the information provided.
  Endorsement: The publisher and the editors do not endorse any products or services that are advertised.
  Disclaimer: Neither the publisher nor the editors will be legally liable for any of the content of advertisements.
  
  

16. Direct Marketing

The journal is disseminated via the journal website. Invitations to submit a manuscript are usually directed at presenters at conferences, seminars, and workshops if the topics of their presentations are related to the aims and scope of the journal.